SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023283
Filing Date
2022-11-08
Accepted
2022-11-08 16:36:53
Documents
60
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xene-20220930.htm   iXBRL 10-Q 3251991
2 EX-10.1 xene-ex10_1.htm EX-10.1 203118
3 EX-31.1 xene-ex31_1.htm EX-31.1 20790
4 EX-31.2 xene-ex31_2.htm EX-31.2 20760
5 EX-32.1 xene-ex32_1.htm EX-32.1 15162
6 EX-32.2 xene-ex32_2.htm EX-32.2 14391
  Complete submission text file 0000950170-22-023283.txt   9146726

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xene-20220930_lab.xml EX-101.LAB 357595
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xene-20220930_pre.xml EX-101.PRE 250112
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xene-20220930.xsd EX-101.SCH 45742
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xene-20220930_def.xml EX-101.DEF 125955
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xene-20220930_cal.xml EX-101.CAL 45266
54 EXTRACTED XBRL INSTANCE DOCUMENT xene-20220930_htm.xml XML 1573403
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 221369488
SIC: 2834 Pharmaceutical Preparations